Search Results for: Biomed-Lublin

Maksymilian Swiniarski becomes the President of the Management Board of Biomed-Lublin
|

Maksymilian Swiniarski becomes the President of the Management Board of Biomed-Lublin

According to the decision of the supervisory board of Biomed-Lublin, Maksymilian Swiniarski will become the president of the company’s board as of 1 January 2022. At the same time, Piotr Fic resigned from the position of Vice-President of the Board acting as President. The new President of the Management Board of Biomed-Lublin, Maksymilian Swiniarski, has…

Biomed-Lublin with the contract for co-financing under OP Intelligent Development

Biomed-Lublin with the contract for co-financing under OP Intelligent Development

On 15 December 2020, Biomd-Lubin signed an agreement with the Minister of Finance, Funds and Regional Policy for co-financing the Project: “BCG biotechnological innovation centre”. As part of these funds, the company received nearly PLN 29.2m for the creation of the centre, in order to develop technologies related to vaccinology in the prevention of tuberculosis…

Marcin Pirog resigns from the position of President of the Management Board of Biomed-Lublin

Marcin Pirog resigns from the position of President of the Management Board of Biomed-Lublin

Marcin Pirog is no longer the President of the Management Board of Biomed-Lublin. On 30 November, he submitted a statement of resignation from his position. What was the reason? Resignation after more than three years of holding the office of the President Marcin Pirog has been President of the Management Board of Biomed-Lublin since June…

Changes to the Biomed-Lublin Management Board

Changes to the Biomed-Lublin Management Board

Piotr Fic has been appointed Vice President of the Management Board in Biomed-Lublin, according to the latest current company report. Until now, he has been a member of the Management Board for operational matters. The company also announced the appointment of two new board members. Competence and operational support for Biomed-Lublin Recently a lot has…

Tuberculosis vaccine returns to production line
| |

Tuberculosis vaccine returns to production line

At the turn of 2018 and 2019 Biomed-Lublin had problems with the quality of the Onko BCG 100 medicinal product and the BCG 10 tuberculosis vaccine. In 2019, none of the tested series was defective. Newborns will get a tuberculosis vaccine The tuberculosis vaccine is an obligatory vaccination of newborns before discharge from the neonatal…